Are There Gender Differences in Outcomes after the Cox-Maze Procedure for Atrial Fibrillation?

Abstract

Objective

Atrial fibrillation (AF) management suggests that women do not tolerate medication rhythm control strategies as well as men do; however, AF percutaneous catheter ablation has been found to be favorable. The study purpose was to compare the sex-based outcomes for patients who undergo the Cox-Maze procedure for AF.

Methods

Data were collected through our AF surgical ablation registry. Rhythm was verified by electrocardiogram and 24-hour holter at 6 and 12 months. General health-related quality of life (Short-Form 12) and specific AF symptom burden (Atrial Fibrillation Symptom Checklist: Frequency and Severity, version 3) were obtained at baseline and 12 months.

Results

Since 2005, a total of 540 patients have undergone a Cox-Maze procedure (34% were women). The women presented with higher operative risk [additive European System for Cardiac Operative Risk Evaluation (EuroSCORE), 6.71 ± 2.61 vs 5.25 ± 2.80, t = 5.85, P < 0.001], higher rates of congestive heart failure (49% vs 32%, P < 0.001), and more concomitant mitral valve procedures (32% vs 19%, P = 0.001). Perioperative outcomes were similar. Return to sinus rhythm off antiarrhythmics were not different at 6 and 12 months (78% vs 75%, P = 0.53, and 81% vs 80%, P = 1.00, respectively). Cumulative 2-year survival (93.9% for the men and 89.3% for the women) was not different for all-cause mortality (hazard ratio, 1.47; confidence interval, 0.68–3.21; P = 0.33) and cardiac-related mortality [women: 10/14 (71%) vs men 7/11 (64%), P = 1.00]. Health-related quality of life showed significant improvement; AF symptoms significantly decreased across the sexes.

Conclusions

Outcomes after the Cox-Maze procedure are similar across sex. Atrial fibrillation surgical ablation should be considered a treatment option for women—it is safe and effective, improves general health-related quality of life, and reduces AF symptom burden.

Keywords

Surgical ablation Gender Outcomes Longitudinal follow-up

Get full access to this article

View all access options for this article.

References

A.S.

, Hylek

E.M.

, Phillips

K.A.

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370–2375.

Chugh

S.S.

, Blackshear

J.L.

, Shen

W.K.

, Hammill

S.C.

, Gersh

B.J.

Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001; 37: 371–378.

Lloyd-Jones

D.M.

, Wang

T.J.

, Leip

E.P.

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110: 1042–1046.

Alonso

, Agarwal

S.K.

, Soliman

E.Z.

Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2009; 158: 111–117.

Prineas

R.J.

, Soliman

E.Z.

, Howard

The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS study [published online ahead of print June 27, 2009]. J Epidemiol. 2009; 19: 177–181.

Volgman

A.S.

, Manankil

M.F.

, Mookherjee

, Trohman

R.G.

Women with atrial fibrillation: greater risk, less attention. Gend Med. 2009; 6: 419–432.

Wyse

D.G.

, Waldo

A.L.

, DiMarco

J.P.

, for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347: 1825–1833.

Van Gelder

I.C.

, Hagens

V.E.

, Bosker

H.A.

, for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002; 347: 1834–1840.

Rienstra

, Van Veldhuisen

D.J.

, Hagens

V.E.

, for the RACE Investigators. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2005; 46: 1298–1306.

10.

Michelena

H.I.

, Powell

B.D.

, Brady

P.A.

, Friedman

P.A.

, Ezekowitz

M.D.

Gender in atrial fibrillation: ten years later. Gend Med. 2010; 7: 206–217.

11.

Santangeli

, di Biase

, Pelargonio

, Natale

Outcome of invasive electrophysiological procedures and gender: are males and females the same?

J Cardiovasc Electrophysiol. 2011; 22: 605–612.

12.

Simon

H.U.

, Sinha

A.M.

, Horack

Abstract 12585: gender and left atrial ablation for atrial fibrillation: outcome data from the German Ablation Registry. Circulation. 2010; 122: A12585.

13.

Cox

J.L.

, Schuessler

R.B.

, D'Agostino

H.J.

Jr. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991; 101: 569–583.

14.

Cox

J.L.

, Ad

New surgical and catheter-based modifications of the Maze procedure. Semin Thorac Cardiovasc Surg. 2000; 12: 68–73.

15.

Weimar

, Bailey

M.S.

, Watanabe

The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol. 2011; 31: 47–54.

16.

Hunt

, Henry

, Ad

Using multiple databases to produce comprehensive follow-up in an effort to enhance evaluation of outcome measurements: surgical ablation (Maze) exemplar [published online ahead of print January 19, 2011]. J Healthc Qual. 2011; 33: 50–63.

17.

, Henry

, Hunt

, Stone

The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation. J Thorac Cardiovasc Surg. 2010; 139: 1146–1152.

18.

Ware

, Kosinski

, Turner-Bowker

How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI: Quality Metric Inc; 2002.

19.

Jenkins

L.S.

Test-Specifications for the Bubien and Kay (Revised Jenkins) Symptom Checklist: Frequency and Severity. Baltimore, MD: University of Maryland Press; 1993.

20.

Bubien

R.S.

, Knotts-Dolson

S.M.

, Plumb

V.J.

, Kay

G.N.

Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996; 94: 1585–1591.

21.

Jenkins

L.S.

, Brodsky

, Schron

Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005; 149: 112–120.

22.

Dorian

, Jung

, Newman

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000; 36: 1303–1309.

23.

Data analysis of The Society of Thoracic Surgeons National Adult Cardiac Surgery Database. 2007. Available at: http://www.sts.org/quality-research-patient-safety/quality. Accessed February 24, 2013.

24.

Calkins

, Brugada

, Packer

D.L.

, for the Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; The Society of Thoracic Surgeons. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and The Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, The Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007; 9: 335–379.

25.

, Henry

, Hunt

, Barnett

, Stone

The Cox-Maze III procedure success rate: comparison by electrocardiogram, 24-hour holter monitoring and long-term monitoring. Ann Thorac Surg. 2009; 88: 101–105.

26.

Henry

, Ad

Long-term monitoring for patients after surgical ablation of atrial fibrillation: are all devices the same?

Innovations (Phila). 2010; 5: 259–264.

27.

Wolbrette

D.L.

Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol. 2003; 91: 39D–44D.

28.

American Heart Association. Heart disease and stroke statistics—2011 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Available at: http://www.heart.org/HEARTORG/. Accessed February 24, 2013.

29.

Kerr

C.R.

, Humphries

Gender-related differences in atrial fibrillation. J Am Coll Cardiol. 2005; 46: 1307–1308.

30.

Paquette

, Roy

, Talajic

Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol. 2000; 86: 764–768.

31.

Fang

M.C.

, Singer

D.E.

, Chang

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005; 112: 1687–1691.

32.

Roten

, Rimoldi

S.F.

, Schwick

Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol. 2009; 32: 622–626.

33.

Reid

J.M.

, Dai

, Gubitz

G.J.

, Kapral

M.K.

, Christian

, Phillips

S.J.

Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke. 2008; 39: 1090–1095.

34.

Friberg

, Scharling

, Gadsboll

, Truelsen

, Jensen

G.B.

, for the Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004; 94: 889–894.

35.

Forster

, Gass

, Kern

Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009; 40: 2428–2432.

36.

Lip

G.Y.

, Nieuwlaat

, Pisters

, Lane

D.A.

, Crijns

H.J.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010; 137: 263–272.

37.

, Henry

, Schlauch

, Holmes

S.D.

, Hunt

The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation. Ann Thorac Surg. 2010; 90: 1257–1262.

38.

Hammond

, Salamonson

, Davidson

, Everett

, Andrew

Why do women underestimate the risk of cardiac disease? A literature review. Aust Crit Care. 2007; 20: 53–59.

39.

Perelman

, Mateus

, Fernandes

Gender equity in treatment for cardiac heart disease in Portugal. Soc Sci Med. 2010; 71: 25–29.

40.

Patel

, Armaganijan

L.V.

, Morillo

C.A.

Atrial fibrillation catheter ablation in females: same hardware, different findings. Expert Rev Cardiovasc Ther. 2011; 9: 1391–1395.

41.

Patel

, Mohanty

, Di Biase

Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010; 7: 167–172.

42.

Dagres

, Clague

J.R.

, Breithardt

, Borggrefe

Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003; 42: 1103–1107.

43.

Forleo

G.B.

, Tondo

, De Luca

Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007; 9: 613–620.

44.

Spragg

D.D.

, Dalal

, Cheema

Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol. 2008; 19: 627–631.

45.

Waller

C.G.

Understanding prehospital delay behavior in acute myocardial infarction in women. Crit Pathw Cardiol. 2006; 5: 228–234.

46.

Rosenfeld

A.G.

Treatment-seeking delay among women with acute myocardial infarction: decision trajectories and their predictors. Nurs Res. 2004; 53: 225–236.

47.

Harralson

T.L.

Factors influencing delay in seeking treatment for acute ischemic symptoms among lower income, urban women. Heart Lung. 2007; 36: 96–104.

48.

Kaul

, Chang

W.C.

, Westerhout

C.M.

, Graham

M.M.

, Armstrong

P.W.

Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. CMAJ. 2007; 177: 1193–1199.

49.

Canto

J.G.

, Rogers

W.J.

, Goldberg

R.J.

, for the NRMI Investigators. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012; 307: 813–822.

50.

Conen

, Tedrow

U.B.

, Koplan

B.A.

, Glynn

R.J.

, Buring

J.E.

, Albert

C.M.

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009; 119: 2146–2152.

51.

Conen

, Ridker

P.M.

, Everett

B.M.

A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women [published online ahead of print May 25, 2010]. Eur Heart J. 2010; 31: 1730–1736.

52.

Aguado-Romeo

M.J.

, Màrquez-Calderón

, Buzón-Barrera

M.L.

, for the Medical Practice Variations Andalusian Group. Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures. BMC Health Serv Res. 2007; 7: 110.

53.

Miyasaka

, Barnes

M.E.

, Gersh

B.J.

Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med. 2007; 120: 357–363.

54.

Barnett

S.D.

, Ad

Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006; 131: 1029–1035.

55.

How do we spell maze? A dialogue concerning definitions and goals. J Thorac Cardiovasc Surg. 2006; 132: 1253–1255.

56.

The challenge of defining procedural endpoints for the surgical treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2012; 41: 119–120.